141 related articles for article (PubMed ID: 12559256)
1. Informed consent for prostate-specific antigen screening.
Carter HB
Urology; 2003 Jan; 61(1):13-4. PubMed ID: 12559256
[No Abstract] [Full Text] [Related]
2. Informed consent for prostate cancer screening--a call for equity in medical interventions.
Thompson IM
Urology; 2003 Jan; 61(1):15-6. PubMed ID: 12559257
[No Abstract] [Full Text] [Related]
3. Informed consent for prostate-specific antigen-based screening.
Brawley OW
Urology; 2003 Jan; 61(1):10-2. PubMed ID: 12559255
[No Abstract] [Full Text] [Related]
4. Informed consent for prostate-specific antigen screening.
Wilkinson S; Chodak G
Urology; 2003 Jan; 61(1):2-4. PubMed ID: 12559252
[No Abstract] [Full Text] [Related]
5. Informed consent for prostate-specific antigen testing.
Gann PH
Urology; 2003 Jan; 61(1):5-6. PubMed ID: 12559253
[No Abstract] [Full Text] [Related]
6. Informed consent for prostate-specific antigen screening.
Catalona WJ
Urology; 2003 Jan; 61(1):17-9. PubMed ID: 12559258
[No Abstract] [Full Text] [Related]
7. What patients should be told before agreeing to a blood test that could change their lives.
Talcott JA
Urology; 2003 Jan; 61(1):7-9. PubMed ID: 12559254
[No Abstract] [Full Text] [Related]
8. Informed consent for prostate-specific antigen-based screening--European view.
Ito K; Schrder FH
Urology; 2003 Jan; 61(1):20-2. PubMed ID: 12559259
[No Abstract] [Full Text] [Related]
9. Screening for prostate cancer. How can patients give informed consent?
Marshall KG
Can Fam Physician; 1993 Nov; 39():2385-90. PubMed ID: 7505673
[TBL] [Abstract][Full Text] [Related]
10. Making an informed choice about PSA screening.
Ward J; Gattellari M
Aust Fam Physician; 2001 Jul; 30(7):715-6. PubMed ID: 11558209
[No Abstract] [Full Text] [Related]
11. What should men know about prostate-specific antigen screening before giving informed consent?
Chan EC; Sulmasy DP
Am J Med; 1998 Oct; 105(4):266-74. PubMed ID: 9809686
[TBL] [Abstract][Full Text] [Related]
12. Screening for prostate cancer: informing men about their options.
Mahon SM
Clin J Oncol Nurs; 2005 Oct; 9(5):625-7. PubMed ID: 16235590
[No Abstract] [Full Text] [Related]
13. Promoting informed decision making about prostate cancer screening.
Chan EC
Compr Ther; 2001; 27(3):195-201. PubMed ID: 11569319
[TBL] [Abstract][Full Text] [Related]
14. Consent before testing men for prostate cancer--a challenge?
Hirst G
Aust Fam Physician; 2005 Oct; 34(10):888. PubMed ID: 16217582
[No Abstract] [Full Text] [Related]
15. Screening for prostate cancer remains controversial.
Neal DE; Donovan JL; Martin RM; Hamdy FC
Lancet; 2009 Oct; 374(9700):1482-3. PubMed ID: 19664817
[No Abstract] [Full Text] [Related]
16. Missing the mark on prostate-specific antigen screening.
Miller DC; Hollenbeck BK
JAMA; 2011 Dec; 306(24):2719-20. PubMed ID: 22203542
[No Abstract] [Full Text] [Related]
17. How can rates of prostate-specific antigen screening be reduced in men aged 80 and older?
Whittle J; Zablocki CJ
J Am Geriatr Soc; 2010 Apr; 58(4):757-9. PubMed ID: 20398158
[No Abstract] [Full Text] [Related]
18. Recommendations on use of prostate-specific antigen for prostate cancer screening.
Garnick MB
JAMA; 2012 Apr; 307(13):1372; author reply 1372-4. PubMed ID: 22474197
[No Abstract] [Full Text] [Related]
19. Editorial panel on informed consent for PSA screening.
Ramsden AR; Chodak G
Urology; 2003 Sep; 62(3):589. PubMed ID: 12946782
[No Abstract] [Full Text] [Related]
20. Prostate specific antigen: a useful screening test?
Concato J
Cancer J; 2000 Apr; 6 Suppl 2():S188-92. PubMed ID: 10803835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
